Suppliers / Glenmark Pharmaceuticals s.r.o

Glenmark Pharmaceuticals s.r.o

India 970 employees Updated 9 July 2026

Glenmark Pharmaceuticals s.r.o is an API and finished-dose manufacturer based in India. It appears in 2,751 regulatory filings across 40 regulators, without an active US DMF or CEP on file. Its filings concentrate with MHRA (UK), EMA and US FDA. Its GMP standing is certified by EMA, CDSCO (India) and ANVISA (Brazil), among 11 authorities. Its most recent recorded inspection, by US FDA, closed on 20 September 2024 as NAI.

0
active US DMFs
0
valid CEPs
12
registered plants
2,751
filings across 40 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
0 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 20 September 2024 NAI US FDA
  • 15 December 2023 NAI US FDA
  • 22 June 2022 OAI US FDA
  • 20 May 2022 OAI US FDA
  • 19 May 2022 OAI US FDA
  • 25 February 2020 NAI US FDA
  • 21 February 2020 NAI US FDA
  • 13 September 2019 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Nasik, United Arab Emirates Not on file
Tehsil Baddi, United Arab Emirates Not on file
Goa, United Arab Emirates Not on file
Himachal Pradesh, United Arab Emirates Not on file
Parque industrial De Pilar, United Arab Emirates Not on file
SAO PAULO, Brazil Not on file

6 further sites are on record.

What they file, and where

Molecule Regulators Docs
Lornoxicam SFDA (Saudi Arabia) 4
Desloratadine SFDA (Saudi Arabia) 3
Adapalene SFDA (Saudi Arabia) 2
Apremilast SFDA (Saudi Arabia) 2
Deferasirox SFDA (Saudi Arabia) 2
Glimepiride SFDA (Saudi Arabia) 2
Perindopril SFDA (Saudi Arabia) 2
Sitagliptin SFDA (Saudi Arabia) 2
Apixaban SFDA (Saudi Arabia) 1
Atovaquone SFDA (Saudi Arabia) 1
Show all 27 molecules on file
Esomeprazole SFDA (Saudi Arabia) 1
Etoricoxib SFDA (Saudi Arabia) 1
Ezetimibe SFDA (Saudi Arabia) 1
Fluconazole SFDA (Saudi Arabia) 1
Lurasidone SFDA (Saudi Arabia) 1
Nintedanib SFDA (Saudi Arabia) 1
Olmesartan Medoxomil SFDA (Saudi Arabia) 1
Perindopril Erbumine SFDA (Saudi Arabia) 1
Perindopril-Tert-Butylamine SFDA (Saudi Arabia) 1
Rasagiline SFDA (Saudi Arabia) 1
Rosuvastatin SFDA (Saudi Arabia) 1
Tazarotene SFDA (Saudi Arabia) 1
Telmisartan SFDA (Saudi Arabia) 1
Ticagrelor SFDA (Saudi Arabia) 1
Tofacitinib SFDA (Saudi Arabia) 1
Vildagliptin SFDA (Saudi Arabia) 1
Voriconazole SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Show 132 more molecule pages
Benzoyl Peroxide finished dose Betamethasone finished dose Bicalutamide finished dose Brimonidine finished dose Bromhexine finished dose Budesonide finished dose Caffeine finished dose Capecitabine finished dose Carbocisteine finished dose Carboplatin finished dose Cefdinir finished dose Cefuroxime finished dose Cefuroxime Axetil finished dose Cetirizine finished dose Chlorphenamine finished dose Chlorpheniramine finished dose Chlorpromazine finished dose Chlorthalidone finished dose Ciclopirox finished dose Cilostazol finished dose Ciprofloxacin finished dose Citalopram finished dose Clarithromycin finished dose Clindamycin finished dose Clobetasol finished dose Clopidogrel finished dose Clotrimazole finished dose Codeine finished dose Dapagliflozin finished dose Desloratadine API Desogestrel finished dose Dextromethorphan finished dose Diclofenac finished dose Diltiazem finished dose Doxycycline finished dose Drospirenone finished dose Dutasteride finished dose Emtricitabine finished dose Enalapril finished dose Escitalopram finished dose Esomeprazole API Estradiol finished dose Ethinylestradiol finished dose Etoricoxib API Ezetimibe API Famotidine finished dose Fluconazole API Fluticasone finished dose Formoterol finished dose Gabapentin finished dose Gentamicin finished dose Glimepiride API Guaifenesin finished dose Hydralazine finished dose Hydrochlorothiazide finished dose Hydrocortisone finished dose Ibandronic Acid finished dose Imiquimod finished dose Indapamide finished dose Indomethacin finished dose Itraconazole finished dose Ketoconazole finished dose Lacosamide finished dose Lamotrigine finished dose Lansoprazole finished dose Latanoprost finished dose Lenalidomide finished dose Letrozole finished dose Levocetirizine finished dose Levofloxacin finished dose Levonorgestrel finished dose Lidocaine finished dose Loratadine finished dose Meloxicam finished dose Memantine finished dose Meropenem finished dose Metformin finished dose Miconazole finished dose Minoxidil finished dose Mirabegron finished dose Mometasone finished dose Montelukast finished dose Mupirocin finished dose Nebivolol finished dose Neomycin finished dose Nitrofurantoin finished dose Norethisterone finished dose Nystatin finished dose Olanzapine finished dose Olmesartan Medoxomil API Olopatadine finished dose Omeprazole finished dose Ondansetron finished dose Paclitaxel finished dose Pantoprazole finished dose Paracetamol finished dose Perindopril API Phenylephrine finished dose Polymyxin B finished dose Pramipexole finished dose Pregabalin finished dose Progesterone finished dose Quetiapine finished dose Ranitidine finished dose Risperidone finished dose Rivaroxaban finished dose Rosuvastatin API Salbutamol finished dose Salmeterol finished dose Saxagliptin finished dose Simvastatin finished dose Sitagliptin API Solifenacin finished dose Sucralfate finished dose Sulfamethoxazole finished dose Tacrolimus finished dose Tamsulosin finished dose Telmisartan API Tenofovir Disoproxil finished dose Terbinafine finished dose Ticagrelor API Timolol finished dose Tinidazole finished dose Tiotropium finished dose Topiramate finished dose Trazodone finished dose Tretinoin finished dose Trimethoprim finished dose Ursodeoxycholic Acid finished dose Vilanterol finished dose Vildagliptin API Zolmitriptan finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
MHRA (UK) 457 6
EMA 304 38
US FDA 278 1
ANVISA (Brazil) 229 8
SAHPRA (ZA) 140 None
DAV (Vietnam) 115 None
CDSCO (India) None 13
NAFDAC (NG) None 3
UZPHARM (UZ) None 3
INVIMA (CO) None 2
MFDS (Korea) None 2
TMDA (TZ) None 1
FDA (GH) None 1

Comparing suppliers?

Choose your molecules and target markets. Glenmark Pharmaceuticals s.r.o comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 58 active litigation matters are on record.
  • The most recent inspection outcome was NAI, on 20 September 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates